STRAINS AND CONSORTIUM OF PROBIOTIC STRAINS OF LACTOBACILLUS CRISPATUS 2029, LACTOBACILLUS GASSERI 2016 AND LACTOBACILLUS PLANTARUM 2025 FOR PRODUCING A BACTERIAL PREPARATION AND STARTER CULTURE

• Main Authors: KHLEBNIKOV, VALENTIN SERGEEVICH, ABRAMOV, VYACHESLAV MIHAYLOVICH, SAKULIN, VADIM KONSTANTINOVICH, PCHELINTSEV, SERGEY YUR'EVICH, MELNIKOV, VYACHESLAV GENNAD'EVICH, KOSAREV, IGOR VASIL'EVICH, VASILENKO, RAISA NIKOLAEVNA
• Format: Patent
• Language: English; French; Russian
• Published: 06.02.2014
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; ENZYMOLOGY; FOODS OR FOODSTUFFS; HUMAN NECESSITIES; HYGIENE; MAKING THEREOF; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MILK OR CHEESE SUBSTITUTES; MUTATION OR GENETIC ENGINEERING; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES USING MICROORGANISMS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES; VINEGAR; WINE

The invention relates to the field of microbiology and biotechnology, particularly to lactobacillus strains which can be used in food and medical biotechnology. Proposed are the strains Lactobacillus crispatus 2029 ( B-2727D), Lactobacillus gasseri 2016 ( KM B-2728DJ) and Lactobacillus plantarum 2025 (BKM B-2731D), which exhibit antagonistic activity with respect to pathogenic and opportunistic microorganisms, and a consortium based on said strains for producing a bacterial preparation, a biologically active additive, a chewing gum, and a direct inoculation starter culture for producing a sour milk functional nutrition product. The consortium includes strains of dominant types of lactobacillus, characteristic of the vaginal microbial community of healthy women of child-bearing age. The consortium has higher antagonistic activity with respect to pathogenic and opportunistic microorganisms than the individual lactobacillus strains of which it is composed. Use of the consortium will make it possible to add to the variety of treatments for maintaining and improving female urogenital health. L'invention se rapporte u domaine de la microbiologie et des biotechnologies, et concerne des souches de lactobacilles utilisées dans biotechnologies alimentaires et médicales. L'invention concerne des souches de Lactobacillus crispatus 2029 ( B-2727D), Lactobacillus gasseri2016 ( KM B-2728D) et Lactobacillus plantarum2025 (BKM B-2731D), qui ont une action antagoniste envers les microorganismes pathogènes et conditionnellement pathogènes, ainsi qu'un consortium obtenu à partir de ces dernières servant à produire une préparation bactérienne, un additif bioactif, des gommes à mâcher, un levain à ajout direct afin d'obtenir un produit lacté acidulé pour l'alimentation fonctionnelle. Le consortium comprend des souches de types dominants de lactobacilles, caractéristiques de la micro-biocénose vaginale de femmes saines en âge de reproduction. Ce consortium possède une plus grande action antagoniste envers les microorganismes pathogènes et conditionnellement pathogènes par rapport aux souches distinctes de lactobacilles entrant dans sa composition. L'utilisation de ce consortium permet d'élargir l'éventail de moyens permettant de préserver et l'améliorer la santé uro-génitale des femmes.